Research and Markets: Daiichi Sankyo Pharmaceuticals is undertaking life-cycle management of the antihypertensive, Olmetec/Benicar, which is one of the companies main growth drivers.
Linked as:
Extract
Research and Markets: Daiichi Sankyo Pharmaceuticals is undertaking life-cycle management of the antihypertensive, Olmetec/Benicar, which is one of the companies main growth drivers.
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c37586) has announced the addition of Daiichi Pharmaceutical Company Intelligence Report from Espicom Bus...
See the full content of this document
Sponsored links
